Prolongation of fetal pancreas allograft survival in mice treated with anti-IL-2 receptor monoclonal antibody (PC61) conjugated with idarubicin.
Koulmanda
M
M
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Melbourne University, Parkville, Victoria, Australia.
Pietersz
G
G
McKenzie
I F
IF
Mandel
T E
TE
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000032:analysis; D016332:Fetal Tissue Transplantation / Q000276:immunology*; D005434:Flow Cytometry; D006085:Graft Survival; D015255:Idarubicin / Q000627:therapeutic use*; D007165:Immunosuppression Therapy; D051379:Mice; D008809:Mice, Inbred C3H; D008808:Mice, Inbred CBA; D016035:Pancreas Transplantation / Q000276:immunology*; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D015375:Receptors, Interleukin-2; D015255:Idarubicin